Venetoclax and Navitoclax in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma

被引:3
|
作者
Alexander, Thomas [1 ]
Lacayo, Norman J. [2 ]
Pullarkat, Vinod A. [3 ]
Jabbour, Elias J. [4 ]
Khaw, Seong Lin [5 ]
Mullighan, Charles G. [6 ,7 ]
Bajel, Ashish [8 ]
Leonard, Jessica [9 ]
Norris, Robin [10 ]
Rubnitz, Jeffrey [11 ]
Vear, Susan I. [12 ]
Schmidt, Michelle [13 ]
Tong, Bo [13 ]
Zhou, Ying [13 ]
Ross, Jeremy A. [13 ]
Rosenwinkel, Lindsey [13 ]
Jacobson, Amanda [13 ]
Kim, Su Young [13 ]
Stock, Wendy [14 ]
机构
[1] Univ N Carolina, Dept Pediat, Chapel Hill, NC USA
[2] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA
[3] City Hope Natl Med Ctr, Dept Hematol HCT, 1500 E Duarte Rd, Duarte, CA 91010 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[5] Royal Childrens Hosp, Melbourne, Vic, Australia
[6] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN USA
[7] St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA
[8] Royal Melbourne Hosp, Melbourne, Vic, Australia
[9] Oregon Hlth & Sci Univ, Sch Med, Portland, OR 97201 USA
[10] Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Cincinnati, OH 45229 USA
[11] St Jude Childrens Res Hosp, Dept Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA
[12] Nationwide Childrens Hosp, Pediat Hematol & Oncol, Columbus, OH USA
[13] AbbVie Inc, N Chicago, IL USA
[14] Univ Chicago, Dept Med, Sect Hematol Oncol, 5841 S Maryland Ave, Chicago, IL 60637 USA
关键词
D O I
10.1182/blood-2018-99-113464
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3966
引用
收藏
页数:4
相关论文
共 50 条
  • [21] Clofarabine-based chemotherapy for relapsed/refractory adult acute lymphoblastic leukemia and lymphoblastic lymphoma. The Spanish experience
    Barba, Pere
    Sampol, Antonia
    Calbacho, Maria
    Gonzalez, Jose
    Serrano, Josefina
    Martinez-Sanchez, Pilar
    Fernandez, Pascual
    Garcia-Boyero, Raimundo
    Bueno, Javier
    Maria Ribera, Josep
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (06) : 631 - 634
  • [22] Correction: Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia
    Deepa Bhojwani
    Richard Sposto
    Nirali N. Shah
    Vilmarie Rodriguez
    Constance Yuan
    Maryalice Stetler-Stevenson
    Maureen M. O’Brien
    Jennifer L. McNeer
    Amrana Quereshi
    Aurelie Cabannes
    Paul Schlegel
    Claudia Rossig
    Luciano Dalla-Pozza
    Keith August
    Sarah Alexander
    Jean-Pierre Bourquin
    Michel Zwaan
    Elizabeth A. Raetz
    Mignon L. Loh
    Susan R. Rheingold
    Leukemia, 2019, 33 : 1061 - 1062
  • [23] Relapsed Acute Lymphoblastic Leukemia
    Schrappe, M.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S26 - S26
  • [24] Relapsed acute lymphoblastic leukemia
    Chen, Judy L.
    Vatanatham, Chaiyaporn C.
    Tsui, Edmund
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2021, 232 : E1 - E1
  • [25] Relapsed Acute Lymphoblastic Leukemia
    Jasmeet Sidhu
    Manash Pratim Gogoi
    Shekhar Krishnan
    Vaskar Saha
    Indian Journal of Pediatrics, 2024, 91 : 158 - 167
  • [26] Relapsed Acute Lymphoblastic Leukemia
    Sidhu, Jasmeet
    Gogoi, Manash Pratim
    Krishnan, Shekhar
    Saha, Vaskar
    INDIAN JOURNAL OF PEDIATRICS, 2024, 91 (02): : 158 - 167
  • [27] Relapsed/Refractory Acute Lymphoblastic Leukemia in Adults: Progress and Challenges
    Guru Murthy, Guru Subramanian
    Atallah, Ehab
    JCO ONCOLOGY PRACTICE, 2022, 18 (07) : 489 - +
  • [28] A novel immunotherapy for relapsed/refractory acute lymphoblastic leukemia (ALL)
    Saini, Uksha
    Hixon, Julie
    Rodrigues, Gisele
    Foley, Christopher
    Chibas, Leniher Castan
    Hamilton, Ross
    Li, Wenqing
    Schafer, Eric S.
    Rheingold, Susan
    Heffernan, Michael
    Breitfeld, Philip
    Durum, Scott
    Varadhachary, Atul
    CANCER RESEARCH, 2023, 83 (07)
  • [29] Immunotherapy of refractory and relapsed acute lymphoblastic leukemia in childhood and adolescence
    Kramm, CM
    Kameda, G
    Bader, P
    Dilloo, D
    MONATSSCHRIFT KINDERHEILKUNDE, 2003, 151 (02) : 154 - 165
  • [30] Importance of blinatumomab in relapsed or refractory acute lymphoblastic leukemia B
    Machet, Antoine
    Gallego-Hernanz, Pilar
    Torregrosa-Diaz, Jose
    Leleu, Xavier
    HEMATOLOGIE, 2016, 22 (01): : 17 - 18